OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
C-X-C Motif Chemokine Receptor 4–Targeted Radioligand Therapy in Hematological Malignancies—Myeloablative Effects, Antilymphoma Activity, and Safety Profile
Niklas Dreher, Anna-Lena Dörrler, Sabrina Kraus, et al.
Clinical Nuclear Medicine (2023) Vol. 49, Iss. 2, pp. 146-151
Open Access | Times Cited: 6
Niklas Dreher, Anna-Lena Dörrler, Sabrina Kraus, et al.
Clinical Nuclear Medicine (2023) Vol. 49, Iss. 2, pp. 146-151
Open Access | Times Cited: 6
Showing 6 citing articles:
Myeloablative Radioligand Therapy Targeting C-X-C Motif Chemokine Receptor 4 in Advanced Multiple Myeloma
Niklas Dreher, Anna-Lena Dörrler, Sabrina Kraus, et al.
Clinical Nuclear Medicine (2025) Vol. 50, Iss. 6, pp. 495-500
Closed Access
Niklas Dreher, Anna-Lena Dörrler, Sabrina Kraus, et al.
Clinical Nuclear Medicine (2025) Vol. 50, Iss. 6, pp. 495-500
Closed Access
CXCR4-Targeted Imaging in Takayasu Arteritis Using 68Ga-Pentixafor PET/CT
Thorsten Derlin, Torsten Witte
Clinical Nuclear Medicine (2025)
Closed Access
Thorsten Derlin, Torsten Witte
Clinical Nuclear Medicine (2025)
Closed Access
Targeted Radiopharmaceutical Therapy for Bone Metastases
Sonia Mahajan, Somali Gavane, Neeta Pandit‐Taskar
Seminars in Nuclear Medicine (2024) Vol. 54, Iss. 4, pp. 497-512
Closed Access | Times Cited: 2
Sonia Mahajan, Somali Gavane, Neeta Pandit‐Taskar
Seminars in Nuclear Medicine (2024) Vol. 54, Iss. 4, pp. 497-512
Closed Access | Times Cited: 2
Pentixather: paving the way for radioligand therapy in oncohematology
Matteo Bauckneht, Luca Filippi
Expert Review of Anticancer Therapy (2024) Vol. 24, Iss. 5, pp. 205-209
Open Access
Matteo Bauckneht, Luca Filippi
Expert Review of Anticancer Therapy (2024) Vol. 24, Iss. 5, pp. 205-209
Open Access
Theranostic strategies in sarcoma: preliminary clinical evidence
Luca Filippi, Cristina Ferrari, Giuseppe Rubini
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 11, pp. 1119-1127
Closed Access
Luca Filippi, Cristina Ferrari, Giuseppe Rubini
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 11, pp. 1119-1127
Closed Access
Recent Updates of PET in Lymphoma: FDG and Beyond
Sung‐Yong Kim, Hyun Woo Chung, Young So, et al.
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2485-2485
Open Access
Sung‐Yong Kim, Hyun Woo Chung, Young So, et al.
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2485-2485
Open Access
Non-[18F]FDG PET-Radiopharmaceuticals in Oncology
Antonia Dimitrakopoulou‐Strauss, Leyun Pan, Christos Sachpekidis
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1641-1641
Open Access
Antonia Dimitrakopoulou‐Strauss, Leyun Pan, Christos Sachpekidis
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1641-1641
Open Access
